SUBSCRIBE
SUBSCRIBE

Alliances

Drug Development
Biopharma Update on the Novel Coronavirus: July 13
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 13, 2020.
July 13, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: July 10
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 10, 2020.
July 9, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Business
Kymera and Sanofi Enter Anti-Inflammatory Deal Worth More than $2 Billion
They will focus on developing and commercializing protein degrader therapies that target IRAK4 in immune-inflammatory diseases, such and rheumatoid arthritis.
July 9, 2020
 · 
3 min read
 · 
Mark Terry
Jonathan Weiss/Shutterstock
Business
Takeda Taps Twist Bioscience to Boost Biologics Discovery Capabilities
Through the partnership, Takeda will have access to Twist’s “Library of Libraries,” a large phage display library created using precisely defined synthetic DNA sequences to discover unique antibodies to important therapeutic targets including GPCRs.
July 8, 2020
 · 
2 min read
 · 
Alex Keown
Business
Foghorn and Merck Ink Strategic Collaboration in Cancer for $425 Million+
Foghorn Therapeutics entered into a strategic collaboration with Merck to leverage Foghorn’s Gene Traffic Control platform for cancer therapies.
July 8, 2020
 · 
3 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: July 8
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 8, 2020.
July 7, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Willy Barton/Shutterstock
Business
GSK, Medicago Forge Agreement to Develop Novel Adjuvanted COVID-19 Vaccine
GlaxoSmithKline is providing its pandemic adjuvant technology to another company to bolster the chances of developing a vaccine against COVID-19.
July 7, 2020
 · 
3 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: July 6
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 6, 2020.
July 6, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Business
Emergent and J&J Ink 5-Year COVID-19 Vaccine Manufacturing Deal
Emergent will handle contract development and manufacturing (CDMO) services in a deal that is valued at about $480 million for the first two years.
July 6, 2020
 · 
3 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: July 3
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 3, 2020.
July 2, 2020
 · 
1 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Press Releases
Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma
August 28, 2025
 · 
3 min read
Press Releases
Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for PrBuccolam® in Canada and announces its approval by Health Canada
August 4, 2025
 · 
4 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.
July 31, 2025
 · 
3 min read
Press Releases
Accelerating Impact: AstraZeneca and Revna Biosciences Expand Access to Lung Cancer Treatment in Ghana
July 30, 2025
 · 
4 min read
Press Releases
JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
July 8, 2025
 · 
5 min read
Press Releases
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it’s Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
June 30, 2025
 · 
8 min read
Press Releases
Mabwell Announces Novel Drug Technology License Agreement with Qilu Pharmaceutical for Albipagrastim alfa for Injection
June 27, 2025
 · 
5 min read
Press Releases
Miraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentric AI Framework for Molecular Data Curation
June 27, 2025
 · 
2 min read
Press Releases
Cyberlux Corporation Signs Strategic MoU with George Mason University to Accelerate Defense Innovation and Technology Commercialization
June 27, 2025
 · 
3 min read
Press Releases
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
June 26, 2025
 · 
5 min read
Press Releases
Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer
June 26, 2025
 · 
10 min read
Press Releases
CMUH and Shine-On Biomedical Lead Taiwan’s Push into Global Exosome-Based Precision Medicine
June 26, 2025
 · 
3 min read
Press Releases
KalVista Pharmaceuticals Enters into Licensing Agreement with Pendopharm to Commercialize Sebetralstat for HAE in Canada
June 26, 2025
 · 
4 min read
Press Releases
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
June 25, 2025
 · 
7 min read
Press Releases
Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.
June 25, 2025
 · 
5 min read
Press Releases
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
June 25, 2025
 · 
5 min read
Press Releases
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
June 25, 2025
 · 
5 min read
Press Releases
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
June 25, 2025
 · 
6 min read
Press Releases
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
June 25, 2025
 · 
5 min read
Press Releases
ONCare Alliance and Exigent Research Launch Groundbreaking Outpatient Bispecifics Program, Redefining Cancer Care Access, Support and Innovation
June 25, 2025
 · 
3 min read
Load More